对齐林斯基，G.；高达，P.的评论。颞下颌关节紊乱病随机对照试验中样本量和效应量计算的应用分析——简短叙述性综述。2024年，，655。
Comment on Zieliński, G.; Gawda, P. Analysis of the Use of Sample Size and Effect Size Calculations in a Temporomandibular Disorders Randomised Controlled Trial-Short Narrative Review. 2024, , 655.
作者信息
Spavieri Juliana Homem Padilha, de Lima Thamiris Costa, Garcêz Luiz Ricardo, Pereira Roger Berg Rodrigues, Claudio Ana Carolina de Jacomo, Chaves Thais Cristina
机构信息
Graduate Program on Physical Therapy, Department of Physical Therapy, Federal University of São Carlos-UFSCar, São Carlos 13.565-905, SP, Brazil.
Department of Physical Therapy, Federal University of São Carlos-UFSCar, Rodovia Washington Luiz, Km 235, São Carlos 13.565-905, SP, Brazil.
出版信息
J Pers Med. 2025 Feb 26;15(3):85. doi: 10.3390/jpm15030085.
Abstract
We have thoroughly reviewed the article titled "Analysis of the Use of Sample Size and Effect Size Calculations in a Temporomandibular Disorders Randomised Controlled Trial-Short Narrative Review" by Zieliński G and Gawda P, recently published in the Journal of Personalized Medicine (2024; 14: 655) [...].
摘要
我们已全面审阅了Zieliński G和Gawda P最近发表在《个性化医学杂志》（2024年；14卷：655页）上的题为“颞下颌关节紊乱病随机对照试验中样本量和效应量计算的应用分析——简短叙述性综述”的文章[……]
相似文献
1
Comment on Zieliński, G.; Gawda, P. Analysis of the Use of Sample Size and Effect Size Calculations in a Temporomandibular Disorders Randomised Controlled Trial-Short Narrative Review. 2024, , 655.
J Pers Med. 2025 Feb 26;15(3):85. doi: 10.3390/jpm15030085.
2
Reply to Spavieri, J.H.P. et al. Comment on "Zieliński, G.; Gawda, P. Analysis of the Use of Sample Size and Effect Size Calculations in a Temporomandibular Disorders Randomised Controlled Trial-Short Narrative Review. 2024, , 655".
J Pers Med. 2025 Feb 26;15(3):86. doi: 10.3390/jpm15030086.
3
Analysis of the Use of Sample Size and Effect Size Calculations in a Temporomandibular Disorders Randomised Controlled Trial-Short Narrative Review.
J Pers Med. 2024 Jun 19;14(6):655. doi: 10.3390/jpm14060655.
4
Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. 2023, , 553.
J Pers Med. 2023 Jun 9;13(6):974. doi: 10.3390/jpm13060974.
5
Correction: Holte et al. A Semi-Automatic Approach for Holistic 3D Assessment of Temporomandibular Joint Changes. 2023, , 343.
J Pers Med. 2024 Dec 19;14(12):1159. doi: 10.3390/jpm14121159.
6
The effectiveness of manual therapy applied to craniomandibular structures in the treatment of temporomandibular disorders: protocol for a systematic review.
Syst Rev. 2021 Mar 8;10(1):70. doi: 10.1186/s13643-021-01623-7.
7
The efficacy of high-intensity laser therapy in wound healing: a narrative review.
Lasers Med Sci. 2024 Aug 3;39(1):208. doi: 10.1007/s10103-024-04146-4.
8
RETRACTED: Hosni Mahmoud, H.A.; Alabdulkreem, E. Bidirectional Neural Network Model for Glaucoma Progression Prediction. 2023, , 390.
J Pers Med. 2024 Jan 29;14(2):148. doi: 10.3390/jpm14020148.
9
Effectiveness of resistance training of masticatory muscles for patients with temporomandibular disorders: protocol for a systematic review.
BMJ Open. 2024 Oct 16;14(10):e083133. doi: 10.1136/bmjopen-2023-083133.
10
A critical review of Dr. Charles S. Greene's article titled "Managing the Care of Patients with Temporomandibular Disorders: a new Guideline for Care" and a revision of the American Association for Dental Research's 1996 policy statement on temporomandibular disorders, approved by the AADR Council in March 2010, published in the Journal of the American Dental Association September 2010.
Cranio. 2012 Jan;30(1):9-24. doi: 10.1179/crn.2012.003.
引用本文的文献
1
Defining Effect Size Standards in Temporomandibular Joint and Masticatory Muscle Research.
Med Sci Monit. 2025 May 1;31:e948365. doi: 10.12659/MSM.948365.
2
Reply to Spavieri, J.H.P. et al. Comment on "Zieliński, G.; Gawda, P. Analysis of the Use of Sample Size and Effect Size Calculations in a Temporomandibular Disorders Randomised Controlled Trial-Short Narrative Review. 2024, , 655".
J Pers Med. 2025 Feb 26;15(3):86. doi: 10.3390/jpm15030086.
本文引用的文献
1
Analysis of the Use of Sample Size and Effect Size Calculations in a Temporomandibular Disorders Randomised Controlled Trial-Short Narrative Review.
J Pers Med. 2024 Jun 19;14(6):655. doi: 10.3390/jpm14060655.
2
Education-Enhanced Conventional Care versus Conventional Care Alone for Temporomandibular Disorders: A Randomized Controlled Trial.
J Pain. 2023 Feb;24(2):251-263. doi: 10.1016/j.jpain.2022.09.012. Epub 2022 Oct 8.
3
Additional effect of pain neuroscience education to craniocervical manual therapy and exercises for pain intensity and disability in temporomandibular disorders: a study protocol for a randomized controlled trial.
Trials. 2021 Sep 6;22(1):596. doi: 10.1186/s13063-021-05532-x.
4
Interpreting Outcomes 3-Clinical Meaningfulness: Linking Evidence to Practice.
J Orthop Sports Phys Ther. 2019 Sep;49(9):677-678. doi: 10.2519/jospt.2019.0705.
5
Research Note: The smallest worthwhile effect of a health intervention.
J Physiother. 2018 Oct;64(4):272-274. doi: 10.1016/j.jphys.2018.07.008. Epub 2018 Sep 3.
6
The smallest worthwhile effect of nonsteroidal anti-inflammatory drugs and physiotherapy for chronic low back pain: a benefit-harm trade-off study.
J Clin Epidemiol. 2013 Dec;66(12):1397-404. doi: 10.1016/j.jclinepi.2013.02.018. Epub 2013 Sep 8.
7
A guide to understanding meta-analysis.
J Orthop Sports Phys Ther. 2011 Jul;41(7):496-504. doi: 10.2519/jospt.2011.3333. Epub 2011 Jul 1.
8
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.
Lancet. 2001 Apr 14;357(9263):1191-4.
Zotero 插件